240 results on '"Zannetti, Antonella"'
Search Results
2. Identification and characterization of a new potent inhibitor targeting CtBP1/BARS in melanoma cells
3. Bispecific aptamer-decorated and light-triggered nanoparticles targeting tumor and stromal cells in breast cancer derived organoids: implications for precision phototherapies
4. Lipid- and polymer-based formulations containing TNF-α inhibitors for the treatment of inflammatory bowel diseases
5. Inhibition of carbonic anhydrases IX/XII by SLC-0111 boosts cisplatin effects in hampering head and neck squamous carcinoma cell growth and invasion
6. Bispecific aptamer-decorated and light-triggered nanoparticles targeting tumor and stromal cells in breast cancer derived organoids: implications for precision phototherapies
7. Optimizing cisplatin delivery to triple-negative breast cancer through novel EGFR aptamer-conjugated polymeric nanovectors
8. The phosphatase Shp1 interacts with and dephosphorylates cortactin to inhibit invadopodia function
9. Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer
10. Identification and characterization of a new potent inhibitor targeting CtBP1/BARS in melanoma cells
11. Development of Cyclic Peptides Targeting the Epidermal Growth Factor Receptor in Mesenchymal Triple-Negative Breast Cancer Subtype
12. Supplementary Methods from Sphingosine Kinase 1 Overexpression Contributes to Cetuximab Resistance in Human Colorectal Cancer Models
13. Supplementary Table 2 from Sphingosine Kinase 1 Overexpression Contributes to Cetuximab Resistance in Human Colorectal Cancer Models
14. Supplementary Figure 6 from Sphingosine Kinase 1 Overexpression Contributes to Cetuximab Resistance in Human Colorectal Cancer Models
15. Supplementary Figure Legend from Sphingosine Kinase 1 Overexpression Contributes to Cetuximab Resistance in Human Colorectal Cancer Models
16. Supplementary Figure 4 from Sphingosine Kinase 1 Overexpression Contributes to Cetuximab Resistance in Human Colorectal Cancer Models
17. Supplementary Figure 3 from Sphingosine Kinase 1 Overexpression Contributes to Cetuximab Resistance in Human Colorectal Cancer Models
18. Supplementary Figure 1 from Sphingosine Kinase 1 Overexpression Contributes to Cetuximab Resistance in Human Colorectal Cancer Models
19. Supplementary Figure 2 from Sphingosine Kinase 1 Overexpression Contributes to Cetuximab Resistance in Human Colorectal Cancer Models
20. Supplementary Table 1 from Sphingosine Kinase 1 Overexpression Contributes to Cetuximab Resistance in Human Colorectal Cancer Models
21. Supplementary Figure 5 from Sphingosine Kinase 1 Overexpression Contributes to Cetuximab Resistance in Human Colorectal Cancer Models
22. Breast Cancer: From Pathophysiology to Novel Therapeutic Approaches 2.0
23. Inhibition of Bone Marrow-Mesenchymal Stem Cell-Induced Carbonic Anhydrase IX Potentiates Chemotherapy Efficacy in Triple-Negative Breast Cancer Cells
24. A novel antagonist of CXCR4 prevents bone marrow-derived mesenchymal stem cell-mediated osteosarcoma and hepatocellular carcinoma cell migration and invasion
25. Tissue Inhibitor of Metalloproteinases-1 Overexpression Mediates Chemoresistance in Triple-Negative Breast Cancer Cells.
26. Expression of SARS-Cov-2 Entry Factors in Patients with Chronic Hepatitis
27. Aptamer-Functionalized Nanoparticles Mediate PD-L1 siRNA Delivery for Effective Gene Silencing in Triple-Negative Breast Cancer Cells
28. 99mTc-MIBI in the Evaluation of Breast Cancer Biology
29. Abstract 367: Nano-immunotherapy in TNBC: Aptamer-based nanoparticles for PD-L1 siRNA delivery to cancer cells
30. Abstract 1040: Blocking hypoxia-induced carbonic anhydrases 9 enhances sensibility to cisplatin of head and neck squamous carcinoma
31. Additional file 1 of Inhibition of carbonic anhydrases IX/XII by SLC-0111 boosts cisplatin effects in hampering head and neck squamous carcinoma cell growth and invasion
32. Optimization of Short RNA Aptamers for TNBC Cell Targeting
33. Preclinical Imaging Evaluation of miRNAs’ Delivery and Effects in Breast Cancer Mouse Models: A Systematic Review
34. Editorial: Tumor Microenvironment: Molecular Mechanisms and Signaling Pathways Involved in Metastatic Progression
35. Additional file 2 of The phosphatase Shp1 interacts with and dephosphorylates cortactin to inhibit invadopodia function
36. Additional file 1 of Optimizing cisplatin delivery to triple-negative breast cancer through novel EGFR aptamer-conjugated polymeric nanovectors
37. Optimizing Cisplatin Delivery to Triple-negative Breast Cancer through Novel EGFR Aptamer-conjugated Polymeric Nanovectors
38. A new and selective radiolabeled αVβ3 peptide antagonist as tracer in tumor diagnosis
39. Additional file 1 of Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer
40. Bcl-2 overexpression prevents 99mTc-MIBI uptake in breast cancer cell lines
41. Role of Aquaporins in the Physiological Functions of Mesenchymal Stem Cells
42. A Novel Inhibitor of Carbonic Anhydrases Prevents Hypoxia-Induced TNBC Cell Plasticity
43. Inhibition of early 99mTc-MIBI uptake by Bcl-2 anti-apoptotic protein overexpression in untreated breast carcinoma
44. Dynamic coupling of 99mTc-MIBI efflux and apoptotic pathway activation in untreated breast cancer patients
45. Functional imaging of multidrug resistance in breast cancer
46. Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer
47. Abstract 5088: Blocking mesenchymal stem cell-induced CAIX hampers metastatic potential and chemoresistance in TNBC
48. Abstract 5256: Toward biomarkers discovery: Profiling triple-negative breast cancer cells by cell-SELEX
49. New CXCR4 Antagonist Peptide R (Pep R) Improves Standard Therapy in Colorectal Cancer
50. Recruitment of stromal cells into tumour microenvironment promote the metastatic spread of breast cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.